Skip to main
  1. Stocks
  2. Rockwell Medical
  3. Forecast
RMTI

Rockwell Medical (RMTI) Stock Forecast & Price Target

Rockwell Medical (RMTI) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Rockwell Medical is viewed positively because it has regained compliance with Nasdaq listing requirements after the 1-for-10 reverse split, removing an overhang while preserving its listing on the Nasdaq Capital Market. Fundamentally, 2Q26 showed commercial traction with revenue of $17.8M, up 11% from $16.1M in 2025, driven by new Western U.S. customers and higher ordering from existing accounts, while cash, cash equivalents and marketable securities rose to $24.8M and free cash flow from operations was $2.1M. Although higher operating expenses widened the quarterly loss to $0.34 per share, the company’s scale, improving margins and efficiency, and a DCF framework implying about $89M in total firm value support the positive outlook.

Bears say

Rockwell Medical is viewed negatively because the company is expected to underperform a passive index of peers in the same sector, signaling weak relative fundamentals and limited investor appeal. As a healthcare supplier focused on hemodialysis concentrates and mixers, its business depends heavily on dialysis-provider demand, efficient logistics, and sustained commercial execution across the United States and international markets, leaving it vulnerable to operational and competitive pressures. The breadth of products such as CitraPure, RenalPure, and SteriLyte does not appear sufficient to offset the market’s expectation of subpar performance, reinforcing a cautious outlook on the stock.

Rockwell Medical (RMTI) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Rockwell Medical and is not a guaranteed prediction by Public.com or investment advice.

Rockwell Medical (RMTI) Analyst Forecast & Price Prediction

Get the latest Rockwell Medical (RMTI) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Rockwell Medical (RMTI)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Rockwell Medical (RMTI) Forecast

Analysts have given Rockwell Medical (RMTI) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Rockwell Medical (RMTI) has a Strong Buy consensus rating as of Nov 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Rockwell Medical (RMTI)


Rockwell Medical (RMTI) Analyst Forecast & Price Prediction

Get the latest Rockwell Medical (RMTI) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Rockwell Medical (RMTI)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover RMTI stock data and trends